What antibiotics treat CMV?
What antibiotics treat CMV?
There are five FDA-approved treatments for CMV retinitis (intravenous ganciclovir, oral valganciclovir, intravenous foscarnet, intravenous cidofovir, and an ocular device containing ganciclovir) approved for induction and maintenance treatment of CMV retinitis.
Can CMV be cured in babies?
Newborns may develop neurologic problems such as hearing loss. Handwashing can help prevent spread of the virus. Cytomegalovirus infection cannot be cured, but some antiviral drugs can limit the problems caused by infection.
What is the drug of choice for cytomegalovirus?
The drug of choice for treatment of CMV disease is intravenous ganciclovir, although valganciclovir may be used for nonsevere CMV treatment in selected cases. Ganciclovir is a nucleoside analogue that inhibits DNA synthesis in the same manner as acyclovir.
How is congenital CMV treated?
For babies with signs of congenital CMV infection at birth, antiviral medications, primarily valganciclovir, may improve hearing and developmental outcomes. Valganciclovir can have serious side effects and has only been studied in babies with signs of congenital CMV infection.
How do babies get CMV?
In the United States, about 1% of infants are infected with CMV before birth. This happens because the mother had a first-time CMV infection or a reactivated infection during her pregnancy. An infected mother can pass the virus to her child before, during, or after birth.
Can babies with CMV be normal?
According to the Centers for Disease Control and Prevention (CDC), about 0.6 percent of babies born in the United States are infected with cytomegalovirus. Most of these babies appear completely normal at birth, but about 20 percent of them will develop symptoms as they grow.
How common is CMV in newborns?
How long is treatment for CMV?
For treatment of CMV infection and disease, the induction dose of IV ganciclovir is recommended for at least 2–3 weeks [31, 35], but the optimal duration of treatment is not well defined and may be longer, depending on the severity of disease, time to response, and end-organ involvement (table 1) [31, 35].
When do you treat neonatal CMV?
Infants with a diagnosis of congenital CMV that have CNS involvement should be treated with either ganciclovir (6 mg/kg IV every 12 hours) or valganciclovir (16 mg/kg PO every 12 hours) for a total of 6 months (Fig. 3.2). Treatment should begin within the first month of life, ideally <2 weeks.
When should you start treatment for congenital CMV?
Infants congenitally infected with CMV may benefit from antiviral therapy, especially if treatment is initiated within the first month of life. The management and outcome of congenital CMV infection are reviewed below.
Is there any treatment for CMV in newborns?
Treatment for newborns with symptoms is controversial. Treatment with medicine that works against the virus (ganciclovir or valganciclovir) is recommended for some babies with CMV. Babies may get this treatment if they have the following: Babies with hearing loss or small head size may take ganciclovir long-term.
What happens to babies born with congenital cytomegalovirus?
Babies Born with Congenital Cytomegalovirus (CMV) Most babies with congenital CMV never show signs or have health problems. However, some babies have health problems at birth or that develop later. Some babies with congenital CMV infection have health problems that are apparent at birth or that develop later during infancy or childhood.
When to test a baby for congenital CMV?
These specimens must be collected for testing within two to three weeks after the baby is born in order to confirm a diagnosis of congenital CMV infection. For babies with signs of congenital CMV infection at birth, antiviral medications, primarily valganciclovir, may improve hearing and developmental outcomes.
When to discontinue Cytogam for CMV patients?
If renal function deteriorates, discontinuation of the product should be considered. The recommended rate of CYTOGAM infusion for prophylaxis of CMV disease in solid organ transplant patients is 60 mg Ig/kg/hr (see DOSAGE AND ADMINISTRATION ).
